Salta alla navigazione principale
Salta alla ricerca
Salta al contenuto principale
Ordina per
Keyphrases
Advanced Stage
16%
Aggressive Management
16%
Angiogenesis
33%
Angiogenic Response
100%
Biological Behavior
16%
Biomarker Expression
16%
Carbonic Anhydrase IX
16%
CD31
16%
Cox Regression
16%
Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET)
100%
Gene Signature
100%
High Grading
16%
Hypoxia
16%
Hypoxia-inducible factor-1α (HIF-1α)
100%
Immunohistochemistry
16%
Kaplan-Meier
16%
Ki-67
16%
Median Overall Survival
16%
Median Survival
16%
Multivariate Predictors
16%
Overall Survival
33%
Pathological Role
16%
Pathological Variables
16%
Patient Stratification
16%
Receptor 1
16%
Regression Method
16%
Somatostatin Receptor
16%
Somatostatin Receptor 2 (SSTR2)
83%
Survival Outcomes
100%
Survival Prediction
16%
Therapeutic Target
16%
Tissue Markers
16%
Tissue Microarray
33%
Treatment Decisions
16%
Tumor
50%
Tumor Phenotype
100%
Tumor Survival
100%
Univariate Analysis
16%
Vascular Endothelial Growth Factor
16%
Well-differentiated
16%
Medicine and Dentistry
Angiogenesis
33%
Biological Marker
16%
Carbonate Dehydratase IX
16%
Gastroenteropancreatic Neuroendocrine Tumor
66%
Hypoxia
16%
Hypoxia Inducible Factor 1
100%
Immunohistochemistry
16%
Neoplasm
100%
Neuroendocrine Tumor
100%
Overall Survival
50%
Proportional Hazards Model
16%
Somatostatin Receptor 1
16%
Somatostatin Receptor 2
83%
Survival Prediction
16%
Tissue Microarray
33%
Univariate Analysis
16%
Vasculotropin A
16%
Biochemistry, Genetics and Molecular Biology
Angiogenesis
33%
Carbonic Anhydrase
16%
CD31
16%
Hypoxia Inducible Factor 1
100%
Overall Survival
50%
Somatostatin Receptor 1
16%
Somatostatin Receptor 2
83%
Survival Prediction
16%
Tissue Microarray
33%
Vascular Endothelial Growth Factor A
16%